Lv3
250 积分 2023-07-29 加入
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
3天前
已完结
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency
10天前
已完结
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies
15天前
已完结
Global epidemiology of epithelial ovarian cancer
16天前
已完结
PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING
23天前
已完结
T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road Ahead
1个月前
已关闭
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
1个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
1个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1个月前
已完结
皖公网安备34019202002308
